Anat Loewenstein, MD, reviews the evaluation of patients with retinal vein occlusion. Dr. Loewenstein’s discussion on which assessments are and are not necessary may have implications for efficient evaluation and management of disease. Dr. Loewenstein also discusses the connection between early intervention and treatment outcomes, and discusses the efficacy of treatment options such as anti-VEGF agents, steroids, and laser therapy.
Anti-VEGF • Euretina Vienna • Retinal Vein Occlusion, RVO
10 / 12 Series: 2018 Euretina Meeting